Key result
Transapical endocardial LV pacing is linked to a ~10% increase in EF and improved functional status.
Why the study?
Failure of coronary sinus lead implantation for cardiac resynchronization therapy requires alternative approaches, and the feasibility of a transapical implantation technique was evaluated.
Does transapical endocardial left ventricular pacing lead implantation improve LV function and clinical status in patients with failed coronary sinus lead implantation?
Observational (n=20)
Yes
Does transapical endocardial left ventricular pacing lead implantation improve LV function and clinical status in patients with failed coronary sinus lead implantation?
Transapical placement of an LV endocardial pacing lead is a feasible and effective alternative strategy for cardiac resynchronization therapy when coronary sinus lead implantation fails.
Answers are grounded in this paper and cite their sources.
May support transapical LV pacing after failed CS implantation; hypothesis-generating pending prospective trials.
Failure of coronary sinus lead implantation for resynchronization therapy requires alternative approaches. For such events we have developed a transapical implantation technique as a feasible alternative. We report the outcome of this technique and its evolution from a minithoracotomy to a percutaneous approach. Twenty patients underwent alternative resynchronization therapy with transapical endocardial left ventricular (LV) pacing lead implantation in a multicentre, international study between October 2007 and March 2010. Eighteen patients underwent minithoracotomy and transapical puncture under direct observation. Two recent patients had transthoracic echocardiography-guided percutaneous apical puncture to enter the LV cavity. A 19 or 21 ga needle and two-stage Seldinger dilatation with 4 and 7 Fr sheaths were then used to introduce the lead. In the two patients with closed-chest insertion of the electrode there was no puncture related bleeding or lung damage. Lead dislocation occurred in two minithoracotomy patients. Repositioning was performed without re-opening the pleural cavity. One patient developed right-sided implanted cardiac defibrillator lead endocarditis requiring complete system removal. Twelve patients have >1 year follow-up; all have sustained and significant improvement in LV dimensions (diastolic Δ4.2 ± 2.9, systolic Δ7.2 ± 5.8 mm), ejection fraction (Δ9.5 ± 9.6%), and functional status (Δ1.1 ± 0.3). Transapical placement of LV endocardial pacing lead is an effective alternative strategy for cardiac resynchronization. A closed-chest, percutaneous approach is feasible and should offer even less invasive intervention.
No takes yet. Share an insight, caveat, or question.
Kassai et al. (2011) conducted an observational in Failure of coronary sinus lead implantation for resynchronization therapy (n=20). Transapical endocardial left ventricular pacing lead implantation was evaluated on Improvement in LV dimensions, ejection fraction, and functional status. Transapical endocardial left ventricular pacing lead implantation improved ejection fraction and functional status at >1 year follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: